|Podcasts|May 16, 2023
Clinical Studies Take Teamwork
Author(s)Lisa Henderson, Andy Studna, Senior Editor
Doug Warner, MD and CMO for eFFECTOR Therapeutics, discusses the complexities of oncology clinical trials, the important relationship medical directors should have with their clinical study teams, and more.
Doug Warner, MD and CMO for eFFECTOR Therapeutics, a clinical stage biopharma targeting oncology, discusses the complexities of oncology clinical trials, bringing his career-long learnings with Amgen to his current role, and the important relationship medical directors should have with their clinical study teams.
Related Content
Trending on Applied Clinical Trials Online
1
Beyond Patient Centricity: What Rare Disease Research Gets Right
2
AI Moves Patient Recruitment from Trial Bottleneck to Competitive Edge: A 2026 Perspective
3
FDA Reaffirms GCP Standards Amid Growing Concerns Over Foreign Clinical Trial Data
4
Fortrea to Acquire Worldwide Clinical Trials' Early Phase Services Division in $45 Million Deal
5